Scythian Biosciences Corp Stock Canadian Securities Exchange
Equities
CA7840531007
Investment Management & Fund Operators
Sales 2022 | -235.54 -322.02 | Sales 2023 | -31.51 -43.08 | Capitalization | 6.26M 8.56M |
---|---|---|---|---|---|
Net income 2022 | -297M -406M | Net income 2023 | -34M -46.48M | EV / Sales 2022 | -188,347 x |
Net Debt 2022 | 24.76M 33.86M | Net cash position 2023 | 70.4M 96.24M | EV / Sales 2023 | 2,035,264 x |
P/E ratio 2022 |
-0.07
x | P/E ratio 2023 |
-0.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.99% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Kania
CEO | Chief Executive Officer | - | 20-05-18 |
Deena Siblock
BRD | Director/Board Member | - | 23-02-26 |
Corporate Officer/Principal | - | 18-04-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mehdi Azodi
BRD | Director/Board Member | - | 23-02-26 |
Deena Siblock
BRD | Director/Board Member | - | 23-02-26 |
Jason Batista
BRD | Director/Board Member | - | 23-06-06 |
1st Jan change | Capi. | |
---|---|---|
+2.10% | 36.06B | |
+14.98% | 35.6B | |
0.00% | 18.31B | |
+4.05% | 5.36B | |
+4.58% | 3.14B | |
+10.26% | 2.87B | |
+19.40% | 2.82B | |
-16.55% | 2.29B | |
+4.02% | 1.24B |